GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » EV-to-EBITDA

GC Cell (XKRX:144510) EV-to-EBITDA : 152.92 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is GC Cell EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, GC Cell's enterprise value is ₩630,121 Mil. GC Cell's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩4,121 Mil. Therefore, GC Cell's EV-to-EBITDA for today is 152.92.

The historical rank and industry rank for GC Cell's EV-to-EBITDA or its related term are showing as below:

XKRX:144510' s EV-to-EBITDA Range Over the Past 10 Years
Min: -508.32   Med: 92.08   Max: 1220.34
Current: 152.92

During the past 11 years, the highest EV-to-EBITDA of GC Cell was 1220.34. The lowest was -508.32. And the median was 92.08.

XKRX:144510's EV-to-EBITDA is ranked worse than
97.27% of 110 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.325 vs XKRX:144510: 152.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), GC Cell's stock price is ₩36150.00. GC Cell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-453.000. Therefore, GC Cell's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


GC Cell EV-to-EBITDA Historical Data

The historical data trend for GC Cell's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell EV-to-EBITDA Chart

GC Cell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 403.75 99.04 33.31 14.12 66.46

GC Cell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.13 60.31 -384.73 66.46 175.98

Competitive Comparison of GC Cell's EV-to-EBITDA

For the Diagnostics & Research subindustry, GC Cell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GC Cell's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GC Cell's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where GC Cell's EV-to-EBITDA falls into.



GC Cell EV-to-EBITDA Calculation

GC Cell's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=630120.701/4120.546
=152.92

GC Cell's current Enterprise Value is ₩630,121 Mil.
GC Cell's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,121 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GC Cell  (XKRX:144510) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

GC Cell's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=36150.00/-453.000
=At Loss

GC Cell's share price for today is ₩36150.00.
GC Cell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-453.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


GC Cell EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of GC Cell's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


GC Cell (XKRX:144510) Business Description

Traded in Other Exchanges
N/A
Address
30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924
GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell (XKRX:144510) Headlines

No Headlines